OM Outset Medical Inc
- Stocks
- Healthcare
- NASDAQ: OM
Price (delayed)
$12.87
Market cap
$228.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$20.15
Enterprise value
$284.19M
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to
Highlights
OM's EPS has surged by 57% year-on-year and by 31% since the previous quarter
OM's debt has plunged by 51% YoY
The equity has soared by 126% YoY but it has contracted by 9% from the previous quarter
OM's quick ratio is up by 13% year-on-year but it is down by 10% since the previous quarter
Key stats
What are the main financial stats of OM
Market
Valuations
Earnings
Shares outstanding
17.77M
Market cap
$228.65M
Enterprise value
$284.19M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.47
Price to sales (P/S)
1.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.38
Revenue
$119.3M
Gross profit
$43.5M
Operating income
-$78.96M
Net income
-$97.9M
EBIT
-$78.58M
EBITDA
-$71.82M
Free cash flow
-$68.4M
Per share
Balance sheet
Liquidity
EPS
-$20.15
EPS diluted
-$20.15
Free cash flow per share
-$3.85
Book value per share
$8.73
Revenue per share
$6.72
TBVPS
$16.28
Total assets
$288.8M
Total liabilities
$134.02M
Debt
$98.43M
Equity
$154.78M
Working capital
$238.67M
Debt to equity
0.64
Current ratio
7.47
Quick ratio
6.02
Net debt/EBITDA
-0.77
Margins
Efficiency
Dividend
EBITDA margin
-60.2%
Gross margin
36.5%
Net margin
-82.1%
Operating margin
-66.2%
Return on assets
-33.8%
Return on equity
-98.1%
Return on invested capital
-23.9%
Return on capital employed
-31.2%
Return on sales
-65.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OM stock price
How has the Outset Medical stock price performed over time
Intraday
-2.57%
1 week
-9.24%
1 month
-31.58%
1 year
3.04%
YTD
-22.7%
QTD
-33%
Financial performance
How have Outset Medical's revenue and profit performed over time
Revenue
$119.3M
Gross profit
$43.5M
Operating income
-$78.96M
Net income
-$97.9M
Gross margin
36.5%
Net margin
-82.1%
The operating margin has grown by 49% year-on-year and by 18% since the previous quarter
Outset Medical's operating income has increased by 48% YoY and by 15% QoQ
OM's net margin is up by 40% YoY and by 17% from the previous quarter
The net income is up by 38% year-on-year and by 14% since the previous quarter
Price vs fundamentals
How does OM's price correlate with its fundamentals
Growth
What is Outset Medical's growth rate over time
Valuation
What is Outset Medical stock price valuation
P/E
N/A
P/B
1.47
P/S
1.91
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.38
OM's EPS has surged by 57% year-on-year and by 31% since the previous quarter
The equity has soared by 126% YoY but it has contracted by 9% from the previous quarter
OM's price to book (P/B) is 61% lower than its 5-year quarterly average of 3.9 but 16% higher than its last 4 quarters average of 1.3
OM's price to sales (P/S) is 82% lower than its 5-year quarterly average of 10.8 but 78% higher than its last 4 quarters average of 1.1
Outset Medical's revenue has increased by 3.5% from the previous quarter and by 2.5% YoY
Efficiency
How efficient is Outset Medical business performance
OM's return on sales is up by 45% year-on-year and by 17% since the previous quarter
The return on invested capital has increased by 35% year-on-year and by 6% since the previous quarter
Outset Medical's ROE has increased by 33% YoY and by 33% from the previous quarter
Outset Medical's return on assets has increased by 32% YoY and by 12% QoQ
Dividends
What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OM.
Financial health
How did Outset Medical financials performed over time
The total assets is 115% greater than the total liabilities
The total liabilities has declined by 46% year-on-year but it has grown by 2% since the previous quarter
OM's quick ratio is up by 13% year-on-year but it is down by 10% since the previous quarter
OM's debt is 36% less than its equity
The equity has soared by 126% YoY but it has contracted by 9% from the previous quarter
The debt to equity has dropped by 78% year-on-year but it rose by 10% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.